These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 21381391)

  • 1. [Researches on the in silico prediction of structure-activity relationship in the regulatory science sectors].
    Hirose A
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2010; (128):27-8. PubMed ID: 21381391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Perspective of predictive toxicity assessment of in vivo repeated dose toxicity using structural activity relationship].
    Ono A
    Kokuritsu Iyakuhin Shokuhin Eisei Kenkyusho Hokoku; 2010; (128):44-9. PubMed ID: 21381395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the European Chemicals Bureau in promoting the regulatory use of (Q)SAR methods.
    Worth AP; Bassan A; De Bruijn J; Gallegos Saliner A; Netzeva T; Patlewicz G; Pavan M; Tsakovska I; Eisenreich S
    SAR QSAR Environ Res; 2007; 18(1-2):111-25. PubMed ID: 17365963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Promises and pitfalls of quantitative structure-activity relationship approaches for predicting metabolism and toxicity.
    Zvinavashe E; Murk AJ; Rietjens IM
    Chem Res Toxicol; 2008 Dec; 21(12):2229-36. PubMed ID: 19548346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction of rodent carcinogenic potential of naturally occurring chemicals in the human diet using high-throughput QSAR predictive modeling.
    Valerio LG; Arvidson KB; Chanderbhan RF; Contrera JF
    Toxicol Appl Pharmacol; 2007 Jul; 222(1):1-16. PubMed ID: 17482223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative PBT screening using (Q)SAR tools within REACH legislation.
    Zachary M; Greenway GM
    SAR QSAR Environ Res; 2009; 20(1-2):145-57. PubMed ID: 19343589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the number of EINECS compounds that can be covered by (Q)SAR models for acute toxicity.
    Zvinavashe E; Murk AJ; Rietjens IM
    Toxicol Lett; 2009 Jan; 184(1):67-72. PubMed ID: 19041378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure alerts for carcinogenicity, and the Salmonella assay system: a novel insight through the chemical relational databases technology.
    Benigni R; Bossa C
    Mutat Res; 2008; 659(3):248-61. PubMed ID: 18621573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In silico modelling of hazard endpoints: current problems and perspectives.
    Mekenyan O; Dimitrov S; Schmieder P; Veith G
    SAR QSAR Environ Res; 2003; 14(5-6):361-71. PubMed ID: 14758980
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of computer-assisted prediction of toxic effects of chemical substances.
    Simon-Hettich B; Rothfuss A; Steger-Hartmann T
    Toxicology; 2006 Jul; 224(1-2):156-62. PubMed ID: 16707203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictive models for carcinogenicity and mutagenicity: frameworks, state-of-the-art, and perspectives.
    Benfenati E; Benigni R; Demarini DM; Helma C; Kirkland D; Martin TM; Mazzatorta P; Ouédraogo-Arras G; Richard AM; Schilter B; Schoonen WG; Snyder RD; Yang C
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2009 Apr; 27(2):57-90. PubMed ID: 19412856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the nature, evolution and future of quantitative structure-activity relationships (QSAR) in toxicology.
    Veith GD
    SAR QSAR Environ Res; 2004; 15(5-6):323-30. PubMed ID: 15669692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational toxicology in drug development.
    Muster W; Breidenbach A; Fischer H; Kirchner S; Müller L; Pähler A
    Drug Discov Today; 2008 Apr; 13(7-8):303-10. PubMed ID: 18405842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico toxicology for the pharmaceutical sciences.
    Valerio LG
    Toxicol Appl Pharmacol; 2009 Dec; 241(3):356-70. PubMed ID: 19716836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving the applicability of (Q)SARs for percutaneous penetration in regulatory risk assessment.
    Bouwman T; Cronin MT; Bessems JG; van de Sandt JJ
    Hum Exp Toxicol; 2008 Apr; 27(4):269-76. PubMed ID: 18684796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-activity models of chemical carcinogens: state of the art, and new directions.
    Benigni R; Bossa C
    Ann Ist Super Sanita; 2006; 42(2):118-26. PubMed ID: 17033131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic toxicity assessment: employing the best science for human safety evaluation. Part I: Early screening for potential human mutagens.
    Jacobson-Kram D; Contrera JF
    Toxicol Sci; 2007 Mar; 96(1):16-20. PubMed ID: 17194803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alternative methods to safety studies in experimental animals: role in the risk assessment of chemicals under the new European Chemicals Legislation (REACH).
    Lilienblum W; Dekant W; Foth H; Gebel T; Hengstler JG; Kahl R; Kramer PJ; Schweinfurth H; Wollin KM
    Arch Toxicol; 2008 Apr; 82(4):211-36. PubMed ID: 18322675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (Q)SAR modeling and safety assessment in regulatory review.
    Kruhlak NL; Benz RD; Zhou H; Colatsky TJ
    Clin Pharmacol Ther; 2012 Mar; 91(3):529-34. PubMed ID: 22258468
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In silico human and rat Vss quantitative structure-activity relationship models.
    Gleeson MP; Waters NJ; Paine SW; Davis AM
    J Med Chem; 2006 Mar; 49(6):1953-63. PubMed ID: 16539383
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.